Tools for fragment based drug discovery

About ZoBio


ZoBio was founded in 2004 as a spin-off of Leiden University, The Netherlands. ZoBio is self funded and offers primarily research services on a fee-for-service basis to customers across the pharmaceutical and biotechnology industries. Customers include 7 of the top 15 largest pharma and various mid-size pharmaceutical companies. The main activities center around the development and commercialization of biophysical technologies that enable new approaches to drug development.

How we operate

ZoBio’s research services are performed strictly on a fee-for-service basis. This leaves the customers in complete control of resulting IP and no financial strings are attached beyond the contract and project(s). Our projects are staged, success-based and may be milestone-driven upon clearly agreed deliverables. This ensures a minimal risk and minimal upfront commitment. The range of our offerings is constantly expanding and can be tailored to the specific research request and needs your organization have, we are truly flexible.

We have established a track record in the industry with a high number of returning customers. Our aim is to develop long-term collaborations with our partners, in which efficiency and valuable results are the key elements. Once you embark on a project, regardless of its size, you will have one contact person within the ZoBio-team guaranteeing transparent lines of communication and decision making.